Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus
Authors:
- Y. TakadaYTY. Takada
- A. TakadaATA. Takada
- M. FujitaMFM. Fujita
- I. WatanabeIWI. Watanabe
- A. TaminatoATA. Taminato
- T. YoshimiTYT. Yoshimi
- 1 June 1992
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 66 (6) , 765-774
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Verapamil inhibition of 5-hydroxytryptamine (5HT) uptake in rat plateletsEuropean Journal of Pharmacology, 1987
- 9 Diabetes Mellitus, Vascular Disease and ThrombosisClinics in Haematology, 1986
- Platelet Behaviour in Non-Insulin-Dependent Diabetes -Influence of Vascular Complications, Treatment and Metabolic ControlThrombosis and Haemostasis, 1986
- Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserinEuropean Journal of Pharmacology, 1983
- Enhanced in Vivo Platelet Activation in Diabetes MellitusScandinavian Journal of Haematology, 1982
- Tests for Platelet Changes, Acute Phase Reactants and Serum Lipids in Diabetes mellitus and Peripheral Vascular DiseaseThrombosis and Haemostasis, 1982
- Platelet function in diabetes mellitus in relationship to complications, glycosylated haemoglobin and serum lipoproteinsEuropean Journal of Clinical Investigation, 1981
- Liquid-chromatographic determination of serotonin and tryptophan in whole blood and plasma.Clinical Chemistry, 1981
- Inhibitory Effect of Ethanol on 5‐Hydroxytryptamine (Serotonin) Uptake in Human Blood Platelets in VitroActa Pharmacologica et Toxicologica, 1979
- 5‐HYDROXYTRYPTAMINE AND DOPAMINE TRANSPORT BY RAT AND HUMAN BLOOD PLATELETSBritish Journal of Pharmacology, 1978